Codiak BioSciences (NASDAQ:CDAK) Announces Quarterly Earnings Results

Codiak BioSciences (NASDAQ:CDAK – Get Rating) released its quarterly earnings results on Thursday. The company reported ($0.74) EPS for the quarter, beating analysts’ consensus estimates of ($0.88) by $0.14, Fidelity Earnings reports. Codiak BioSciences had a negative net margin of 425.30% and a negative return on equity of 169.73%. Shares of CDAK traded up $0.13 […]

Related Keywords

Codiak Biosciences ,Nicole Barna ,Morgan Stanley ,York Mellon Corp ,Geode Capital Management ,Codiak Biosciences Inc ,Zacks Investment Research ,Goldman Sachs Group ,Blackrock Inc ,Get Rating ,Fidelity Earnings ,Investment Research ,Street Corp ,Capital Management ,New York Mellon Corp ,Nasdaq Cdak ,Ncdak ,Medical ,Earnings ,